Laurel J Mengle-Gaw

Title: Innovations in Pain Management by Laurel J Mengle-Gaw

Introduction

Laurel J Mengle-Gaw is an accomplished inventor based in St. Louis, MO (US). She has made significant contributions to the field of pain management, particularly in the development of methods for transitioning patients from intravenous opioid administration to oral medication. With a total of 3 patents, her work is focused on improving patient care and treatment efficacy.

Latest Patents

One of her latest patents involves methods of converting a patient's treatment regimen from intravenous administration of an opioid to oral co-administration of morphine and oxycodone using a dosing algorithm to provide analgesia. This innovative method includes determining a four-hour average of oral morphine equivalents or a net average hourly intravenous dose. The process involves orally administering a first dose of a morphine-oxycodone combination in a 3:2 ratio by weight every four to six hours. This approach aims to enhance pain management for patients who have previously received opioids intravenously.

Career Highlights

Laurel has been instrumental in advancing pain treatment methodologies. Her work at Qrxpharma Limited has allowed her to focus on developing effective pain management solutions. Her innovative approaches have garnered attention in the medical community, contributing to improved patient outcomes.

Collaborations

Laurel collaborates with notable professionals in her field, including Patricia T Richards and Warren C Stern. These partnerships enhance her research and development efforts, leading to more comprehensive solutions in pain management.

Conclusion

Laurel J Mengle-Gaw's contributions to pain management through her innovative patents reflect her dedication to improving patient care. Her work continues to influence the medical field, paving the way for more effective treatment options.